The Food and Drug Administration (FDA) has announced that it is requiring manufacturers to put a boxed
warning on the prescribing information for the smoking cessation drugs Chantix and Zyban.
From : News Headline for pharmacists about achievements, trends, and changes in the pharmacy industry

